These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 18768894)

  • 1. Unique properties of the chicken TLR4/MD-2 complex: selective lipopolysaccharide activation of the MyD88-dependent pathway.
    Keestra AM; van Putten JP
    J Immunol; 2008 Sep; 181(6):4354-62. PubMed ID: 18768894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4.
    Pålsson-McDermott EM; O'Neill LA
    Immunology; 2004 Oct; 113(2):153-62. PubMed ID: 15379975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.
    Yamamoto M; Sato S; Mori K; Hoshino K; Takeuchi O; Takeda K; Akira S
    J Immunol; 2002 Dec; 169(12):6668-72. PubMed ID: 12471095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-beta.
    Oshiumi H; Sasai M; Shida K; Fujita T; Matsumoto M; Seya T
    J Biol Chem; 2003 Dec; 278(50):49751-62. PubMed ID: 14519765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages.
    Schilling D; Thomas K; Nixdorff K; Vogel SN; Fenton MJ
    J Immunol; 2002 Nov; 169(10):5874-80. PubMed ID: 12421970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a Regulatory Acidic Motif as the Determinant of Membrane Localization of TICAM-2.
    Funami K; Matsumoto M; Enokizono Y; Ishii N; Tatematsu M; Oshiumi H; Inagaki F; Seya T
    J Immunol; 2015 Nov; 195(9):4456-65. PubMed ID: 26408662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential involvement of BB loops of toll-IL-1 resistance (TIR) domain-containing adapter proteins in TLR4- versus TLR2-mediated signal transduction.
    Toshchakov VU; Basu S; Fenton MJ; Vogel SN
    J Immunol; 2005 Jul; 175(1):494-500. PubMed ID: 15972684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gedunin Binds to Myeloid Differentiation Protein 2 and Impairs Lipopolysaccharide-Induced Toll-Like Receptor 4 Signaling in Macrophages.
    Borges PV; Moret KH; Maya-Monteiro CM; Souza-Silva F; Alves CR; Batista PR; Caffarena ER; Pacheco P; Henriques Md; Penido C
    Mol Pharmacol; 2015 Nov; 88(5):949-61. PubMed ID: 26330549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex.
    Youn HS; Lee JY; Fitzgerald KA; Young HA; Akira S; Hwang DH
    J Immunol; 2005 Sep; 175(5):3339-46. PubMed ID: 16116226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRAM is required for TLR2 endosomal signaling to type I IFN induction.
    Stack J; Doyle SL; Connolly DJ; Reinert LS; O'Keeffe KM; McLoughlin RM; Paludan SR; Bowie AG
    J Immunol; 2014 Dec; 193(12):6090-102. PubMed ID: 25385819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Funiculosin variants and phosphorylated derivatives promote innate immune responses via the Toll-like receptor 4/myeloid differentiation factor-2 complex.
    Okamoto N; Mizote K; Honda H; Saeki A; Watanabe Y; Yamaguchi-Miyamoto T; Fukui R; Tanimura N; Motoi Y; Akashi-Takamura S; Kato T; Fujishita S; Kimura T; Ohto U; Shimizu T; Hirokawa T; Miyake K; Fukase K; Fujimoto Y; Nagai Y; Takatsu K
    J Biol Chem; 2017 Sep; 292(37):15378-15394. PubMed ID: 28754693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A unique feature of Toll/IL-1 receptor domain-containing adaptor protein is partially responsible for lipopolysaccharide insensitivity in zebrafish with a highly conserved function of MyD88.
    Liu Y; Li M; Fan S; Lin Y; Lin B; Luo F; Zhang C; Chen S; Li Y; Xu A
    J Immunol; 2010 Sep; 185(6):3391-400. PubMed ID: 20702732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The central leucine-rich repeat region of chicken TLR16 dictates unique ligand specificity and species-specific interaction with TLR2.
    Keestra AM; de Zoete MR; van Aubel RA; van Putten JP
    J Immunol; 2007 Jun; 178(11):7110-9. PubMed ID: 17513760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of TRAM restricts Toll-like receptor 4 signaling in vascular endothelial cells to the MyD88 pathway.
    Harari OA; Alcaide P; Ahl D; Luscinskas FW; Liao JK
    Circ Res; 2006 May; 98(9):1134-40. PubMed ID: 16574902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling of apoptosis through TLRs critically involves toll/IL-1 receptor domain-containing adapter inducing IFN-beta, but not MyD88, in bacteria-infected murine macrophages.
    Ruckdeschel K; Pfaffinger G; Haase R; Sing A; Weighardt H; Häcker G; Holzmann B; Heesemann J
    J Immunol; 2004 Sep; 173(5):3320-8. PubMed ID: 15322195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.
    Mishra V; Pathak C
    J Biomol Struct Dyn; 2019 May; 37(8):1968-1991. PubMed ID: 29842849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of MyD88- and TRIF-dependent signaling pathways of Toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea.
    Youn HS; Lee JY; Saitoh SI; Miyake K; Kang KW; Choi YJ; Hwang DH
    Biochem Pharmacol; 2006 Sep; 72(7):850-9. PubMed ID: 16890209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for ProTα-TLR4/MD-2 binding: molecular dynamics and gravimetric assay studies.
    Omotuyi O; Matsunaga H; Ueda H
    Expert Opin Biol Ther; 2015; 15 Suppl 1():S223-9. PubMed ID: 25604147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of TLR4 polymorphic variants: new insights into TLR4/MD-2/CD14 stoichiometry, structure, and signaling.
    Rallabhandi P; Bell J; Boukhvalova MS; Medvedev A; Lorenz E; Arditi M; Hemming VG; Blanco JC; Segal DM; Vogel SN
    J Immunol; 2006 Jul; 177(1):322-32. PubMed ID: 16785528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain.
    Kawamoto T; Ii M; Kitazaki T; Iizawa Y; Kimura H
    Eur J Pharmacol; 2008 Apr; 584(1):40-8. PubMed ID: 18299127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.